Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/52193
Conference/Presentation Title: | Comparative analysis of pulmonary vein isolation (PVI) alone versus PCI with additional left atrial posterior wall isolation by pulsed field ablation: a single-centre study. | Authors: | Saleemi S.;Dashwood A.;Kader Z.;Bi A.;Ky V.;Young J.;Tian B.;Maung A.;Alison J. ;Kotschet E. ;Healy S.;Alasti M.;Han H.;Bittinger L.;Machado C.;Adam D. | Monash Health Department(s): | Cardiology (MonashHeart) | Institution: | (Saleemi, Dashwood, Kader, Bi, Ky, Young, Alison, Kotschet, Healy, Alasti, Han, Bittinger, Machado, Adam) Monash Health, Melbourne, VIC, Australia (Tian, Maung) Monash University, Melbourne, VIC, Australia |
Presentation/Conference Date: | 30-Jul-2024 | Copyright year: | 2024 | Publisher: | Elsevier Ltd | Publication information: | Heart Lung and Circulation. Conference: 72nd Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Perth Convention and Exhibition Centre, Perth Australia. 33(Supplement 4) (pp S425), 2024. Date of Publication: August 2024. | Journal: | Heart Lung and Circulation | Abstract: | Background: Left atrial posterior wall isolation (LAPWI) presents challenges, particularly with thermal energy sources. Pulsed-field ablation (PFA) offers a new method for achieving this, whilst mitigating procedural complications. Aim(s): Assess the practical feasibility and safety of additional LAPWI using PFA in conjunction with pulmonary vein isolation (PVI), as compared to PVI alone. Method(s): De-identified data from 201 patients undergoing PFA at the Victorian Heart Hospital (VHH) between October 2022 and December 2023 were analysed. Result(s): Demographics and procedurals characteristics are shown in Table 1. The addition of LAPWI prolonged the procedure by an average of 6+/-2.2 minutes and required 25+/-6.5 additional PFA applications. In the PVI + LAPWI group, one major complication occurred at day 7 with acute kidney injury. Anticoagulation was suspended, and the patient experienced a stroke with full resolution. Conversely, the PVI only group experienced three admissions for heart failure and two pericarditis cases. At 30 days, two patients (2.6%) developed atrial arrhythmias in the PVI + LAPWI group compared to seven (5.5%) in the PVI-only cohort. Conclusion(s): The addition of LAPWI by PFA is feasible and safe with minimal procedural duration extension. Longer-term follow-up is required to access efficacy and durability. [Formula presented]Copyright © 2024 | Conference Name: | 72nd Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand | Conference Start Date: | 2024-08-01 | Conference End Date: | 2024-08-04 | Conference Location: | Perth Convention and Exhibition Centre, Perth, Australia | DOI: | http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1016/j.hlc.2024.06.648 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/52193 | Type: | Conference Abstract | Subjects: | anticoagulation atrial fibrillation cerebrovascular accident heart atrium arrhythmia heart failure heart left atrium pericarditis pulmonary vein isolation |
Type of Clinical Study or Trial: | Observational study (cohort, case-control, cross sectional, or survey) |
Appears in Collections: | Conferences |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.